Viewing Study NCT00818259


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2025-12-25 @ 9:21 PM
Study NCT ID: NCT00818259
Status: TERMINATED
Last Update Posted: 2018-09-25
First Post: 2009-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-02-05
Start Date Type: ACTUAL
Primary Completion Date: 2014-01-20
Primary Completion Date Type: ACTUAL
Completion Date: 2014-01-20
Completion Date Type: ACTUAL
First Submit Date: 2009-01-06
First Submit QC Date: None
Study First Post Date: 2009-01-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-10-02
Results First Submit QC Date: None
Results First Post Date: 2014-11-18
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-08-27
Last Update Post Date: 2018-09-25
Last Update Post Date Type: ACTUAL